Renal tumor ablation is a function of patient selection and technique - Not the ablation technology

Cancer

Volumn 113, Issue 10, 2008, Pages 2623-2626

  Cadeddu, Jeffrey A ^a   Raman, Jay D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CONTROL; CANCER RECURRENCE; CRYOABLATION; EDITORIAL; FOLLOW UP; HUMAN; KIDNEY TUMOR; LAPAROSCOPY; PATIENT SELECTION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; TUMOR GROWTH;

ABLATION TECHNIQUES; HUMANS; KIDNEY NEOPLASMS; META-ANALYSIS AS TOPIC; PATIENT SELECTION;

EID: 55849108785     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23897     Document Type: Editorial

References (17)

1. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628-1631.
2. Hock LM, Lynch J, Balaji KC. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of Surveillance, Epidemiology and End Results Program data. J Urol. 2002;167:57-60.
3. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98:1331-1334.
4. Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer. 2008;113:2671-2680.
5. Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe: the small renal mass dilemma - pa meta-analysis and review. J Urol. 2008;179:1227-1234.
6. Zwahlen M, Renehan A, Egger M. Meta-analysis in medical research: potentials and limitations. Urol Oncol. 2008;26:320-329.
7. Raman JD, Cadeddu JA. Re: excise, ablate or observe: the small renal mass dilemma - a meta-analysis and review.-Kunkle DA, Egleston BL, and Uzzo RG. J Urol 2008 Aug 16 [Epub ahead of print].
8. Matin SF, Ahrar K, Cadeddu JA, et al. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol. 2006;176:1973-1977.
9. Permpongkosol S, Link RE, Kavoussi LR, Solomon SB. Percutaneous computerized tomography guided cryoablation for localized renal cell carcinoma: factors influencing success. J Urol. 2006;176:1963-1969; discussion 1968.
10. Atwell TD, Farrell MA, Leibovich BC, et al. Percutaneous renal cryoablation: experience treating 115 tumors. J Urol. 2008;179:2136-2140; discussion 2140-2140.
11. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol. 2005;185:64-71.
12. McDougal WS, Gervais DA, McGovern FJ, Mueller PR. Long-term follow-up of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J Urol. 2005;174:61-63.
13. Hegarty NJ, Gill IS, Desai MM, Remer EM, O'Malley CM, Kaouk JH. Probe-ablative nephron-sparing surgery: cryo ablation versus radiofrequency ablation. Urology. 2006;68(1 suppl):7-13.
14. Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA, Raj GV. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol. 2008;179:75-79; discussion 79-80.
15. Stern JM, Svatek R, Park S, et al. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int. 2007;100:287-290.
16. Varkarakis IM, Allaf ME, Inagaki T, et al. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean follow up. J Urol. 2005;174:456-460; discussion 460.
17. Park S, Cadeddu JA. Outcomes of radiofrequency ablation for kidney cancer. Cancer Control. 2007;14:205-210.